News for Cyclacel Pharmaceuticals, Inc. (CYCC)

KUALA LUMPUR, MALAYSIA, May 15, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. ( CYCC, CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical comp

BERKELEY HEIGHTS, NJ, May 07, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”...

Cyclacel Pharmaceuticals (CYCC) has formalized an Exchange Agreement with FITTERS Diversified Berhad, a company involved in diverse sectors such as fire safety

Cyclacel Pharmaceuticals (CYCC) to acquire Fitters Sdn. Bhd. in a share exchange, expanding into fire safety and real estate sectors.Post-acquisition, Cyclacel

KUALA LUMPUR, MALAYSIA, May 06, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. ( CYCC, CYCCP; ”œCyclacel” or the ”œCompany”) today announced t

**media[615630,615631]**

The company has announced that it will not be offering any securities under the current prospectus. Additionally, it clarified that it will not benefit from any

Cyclacel Pharmaceuticals (CYCC) announces a quarterly dividend of $0.15 per share. Ex-dividend date is April 29, with payment on May 1. Analyst forec

BERKELEY HEIGHTS, N.J., April 02, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. ( CYCC, CYCCP; ”œCyclacel” or the ”œCompany”), a biopharmaceu

Cyclacel Pharmaceuticals (CYCC) reports Q4 GAAP EPS of -$0.33. Discover key insights into their financial performance and outlook.

**media[584431]**

**media[574577]**

**media[552715]**

BERKELEY HEIGHTS, N.J., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. ("Cyclacel") ( CYCC, CYCCP), a biopharmaceutical company that develo

Significant Transaction on December 31, 2024 On December 31, 2024, ARMISTICE CAPITAL, LLC (Trades, Portfolio) executed a noteworthy transaction involving Cyclac

U.S. stocks traded higher midway through trading, with the Nasdaq Composite surging more than 1% on Friday. The Dow traded up 0.61% to 42,648.40 while the NASD...

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 100 points on Friday. Following the market opening, the Dow traded up 0.31% ...

**media[504976]**

Cyclacel Pharmaceuticals announces securities purchase agreement with investor David Lazar, new CEO appointed, and stock up over 69% in premarket trading.